Ultragenyx Historical Income Statement
| RARE Stock | USD 46.02 0.38 0.82% |
Historical analysis of Ultragenyx income statement accounts such as Research Development of 680.9 M, Total Operating Expenses of 1 B, Total Revenue of 456 M or Gross Profit of 408.5 M can show how well Ultragenyx performed in making a profits. Evaluating Ultragenyx income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Ultragenyx's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Ultragenyx latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ultragenyx is a good buy for the upcoming year.
Ultragenyx |
About Ultragenyx Income Statement Analysis
Ultragenyx Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Ultragenyx shareholders. The income statement also shows Ultragenyx investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Ultragenyx Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Ultragenyx. It is also known as Ultragenyx overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Most accounts from Ultragenyx's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Ultragenyx current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ultragenyx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.At present, Ultragenyx's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 325.3 M, whereas EBIT is projected to grow to (515.3 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 13.2M | 18.2M | 26.0M | 16.3M | Interest Income | 1.9M | 11.1M | 26.7M | 28.0M |
Ultragenyx income statement Correlations
Click cells to compare fundamentals
Ultragenyx Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ultragenyx income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 12.5M | 12.3M | 13.2M | 18.2M | 26.0M | 27.3M | |
| Interest Expense | 1.1M | 33.3M | 29.4M | 43.0M | 66.0M | 69.3M | |
| Selling General Administrative | 161.5M | 182.9M | 220.0M | 278.1M | 309.8M | 325.3M | |
| Other Operating Expenses | 527.9M | 601.1M | 733.1M | 1.0B | 1.0B | 1.1B | |
| Operating Income | (424.2M) | (330.1M) | (381.7M) | (648.9M) | (569.2M) | (540.7M) | |
| Ebit | (424.2M) | (152.1M) | (423.6M) | (658.7M) | (542.5M) | (515.3M) | |
| Research Development | 357.4M | 412.1M | 497.2M | 705.8M | 648.4M | 680.9M | |
| Ebitda | (411.7M) | (139.8M) | (410.3M) | (640.5M) | (516.5M) | (490.6M) | |
| Total Operating Expenses | 518.9M | 595.0M | 717.1M | 983.9M | 958.2M | 1.0B | |
| Income Before Tax | (399.4M) | (185.4M) | (453.0M) | (701.7M) | (608.5M) | (578.0M) | |
| Total Other Income Expense Net | 24.7M | 144.8M | (71.2M) | (52.8M) | (39.3M) | (37.3M) | |
| Net Income | (402.7M) | (186.6M) | (454.0M) | (707.4M) | (606.6M) | (576.3M) | |
| Income Tax Expense | 3.3M | 1.2M | 1.0M | 5.7M | (1.8M) | (1.9M) | |
| Total Revenue | 103.7M | 271.0M | 351.4M | 363.3M | 434.2M | 456.0M | |
| Gross Profit | 94.7M | 264.9M | 335.4M | 335.0M | 389.0M | 408.5M | |
| Net Income From Continuing Ops | (402.7M) | (186.6M) | (454.0M) | (707.4M) | (606.6M) | (576.3M) | |
| Cost Of Revenue | 9.0M | 6.1M | 16.0M | 28.3M | 45.2M | 32.3M | |
| Non Operating Income Net Other | 12.5M | 7.6M | 241K | 9.5M | 10.9M | 10.4M | |
| Net Income Applicable To Common Shares | (402.7M) | (186.6M) | (454.0M) | (707.4M) | (636.7M) | (604.8M) | |
| Tax Provision | 3.3M | 1.2M | 1.0M | 5.7M | (1.8M) | (1.7M) | |
| Net Interest Income | 12.1M | (26.3M) | (29.4M) | (31.9M) | (39.3M) | (37.4M) | |
| Interest Income | 13.2M | 7.0M | 1.9M | 11.1M | 26.7M | 28.0M | |
| Reconciled Depreciation | 8.5M | 12.3M | 13.2M | 18.2M | 26.0M | 16.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ultragenyx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultragenyx. If investors know Ultragenyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultragenyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.35) | Revenue Per Share 6.015 | Quarterly Revenue Growth 0.423 | Return On Assets (0.24) | Return On Equity (2.90) |
The market value of Ultragenyx is measured differently than its book value, which is the value of Ultragenyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ultragenyx's value that differs from its market value or its book value, called intrinsic value, which is Ultragenyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultragenyx's market value can be influenced by many factors that don't directly affect Ultragenyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultragenyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultragenyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultragenyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.